Viewing Study NCT05715632


Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2026-01-01 @ 10:45 PM
Study NCT ID: NCT05715632
Status: UNKNOWN
Last Update Posted: 2023-07-14
First Post: 2022-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX
Sponsor: Tang-Du Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module